)
Gossamer Bio (GOSS) investor relations material
Gossamer Bio Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 4, 2026, to be held virtually for shareholder participation.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report, are available online for review and voting.
Voting matters and shareholder proposals
Shareholders will vote on the election of two Class II directors: Russell Cox and Faheem Hasnain.
Ratification of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026, is on the agenda.
Advisory vote on executive compensation for named executive officers is included.
Board of directors and corporate governance
Board recommends voting in favor of all three proposals presented at the annual meeting.
- Virtual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance.GOSS
Proxy filing24 Apr 2026 - Seralutinib improved 6MWD and biomarkers in high-risk PAH, despite a high placebo response.GOSS
Study result22 Apr 2026 - Seralutinib showed promise in subgroups but missed its primary endpoint, triggering strategic shifts.GOSS
Q4 202517 Mar 2026 - Seralutinib advances in global phase III trials, with Chiesi partnership accelerating PH-ILD expansion.GOSS
Presents at Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - Seralutinib's phase III trials progress with strong data, global reach, and robust financial backing.GOSS
Guggenheim Securities Inaugural Healthcare Innovation Conference15 Jan 2026 - PROSERA nears enrollment completion, with Q4 data and commercial launch plans progressing.GOSS
Piper Sandler 36th Annual Healthcare Conference12 Jan 2026 - Seralutinib targets late-stage PAH and PH-ILD markets with best-in-class safety and strong commercial prospects.GOSS
Barclays 27th Annual Global Healthcare Conference 202526 Dec 2025 - Seralutinib advances in phase III with best-in-class safety, efficacy, and global reach.GOSS
Leerink’s Global Healthcare Conference 202526 Dec 2025 - Seralutinib’s phase III data in PH, expected late 2024, could reshape the treatment landscape.GOSS
Emerging Growth Conference 7923 Dec 2025
Next Gossamer Bio earnings date
Next Gossamer Bio earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)